Skip to main content

Advertisement

Table 3 Outcomes and complications of patients with neutropenic pneumonia

From: Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimens

Variables β-lactam group (n = 72) Combination group (n = 93) P-value
30-day all-cause mortality 11 (15.3%) 4 (4.3%) 0.015
90-day all-cause mortality 15 (20.8%) 7 (7.5%) 0.013
Length of hospital stay, days 5.7 (4.4–10.9) 6.0 (4.3–8.6) 0.632
Recurrence of pneumoniaa 4 (5.6%) 3 (3.2%) 0.700
Complications and adverse effectsa
 Complicated pleural effusion 1 (1.4%) 2 (2.2%) 1.000
  CDAD 3 (4.2%) 0 (0.0%) 0.081
  Cardiac eventsb 4 (5.6%) 4 (4.3%) 0.730
  Othersc 8 (11.4%) 7 (7.5%) 0.394
  1. Data are expressed as number (%) of patients or median (IQR)
  2. aWithin 90 days
  3. bCardiac events included arrhythmia, heart failure, and myocardial infarction
  4. cOthers included diarrhea, gastrointestinal bleeding, pneumothorax, epilepsy, and back pain
  5. Abbreviations: CDAD Clostridium difficile-associated diarrhea, IQR interquartile range